165 related articles for article (PubMed ID: 6687638)
21. Combined modality therapy in previously untreated patients with advanced Hodgkin's disease: A 24-year follow-up study.
Salloum E; Doria R; Farber LR; Roberts KB; Cooper DL
Cancer J Sci Am; 1995; 1(4):267-73. PubMed ID: 9166487
[TBL] [Abstract][Full Text] [Related]
22. An elevated serum beta-2-microglobulin level is an adverse prognostic factor for overall survival in patients with early-stage Hodgkin disease.
Chronowski GM; Wilder RB; Tucker SL; Ha CS; Sarris AH; Hagemeister FB; Barista I; Hess MA; Cabanillas F; Cox JD
Cancer; 2002 Dec; 95(12):2534-8. PubMed ID: 12467067
[TBL] [Abstract][Full Text] [Related]
23. [Pregnancies and offspring after MOPP therapy].
Andrieu JM; Ochoa-Molina ME
Nouv Presse Med; 1982 Dec; 11(49):3623-5. PubMed ID: 6897673
[TBL] [Abstract][Full Text] [Related]
24. Will doxorubicin-containing regimens replace MOPP and its variants?
Canellos GP; Rosenberg W
Leukemia; 1991; 5 Suppl 1():50-2. PubMed ID: 1890866
[No Abstract] [Full Text] [Related]
25. People with Hodgkin disease: the nursing challenge.
Le Blanc DH
Nurs Clin North Am; 1978 Jun; 13(2):281-300. PubMed ID: 248744
[No Abstract] [Full Text] [Related]
26. [Combined chemotherapy in Hodgkin's disease].
Somers R; Haanen C; Hart AA; Kroese WF; Sizoo W; Wagener DJ
Ned Tijdschr Geneeskd; 1976 Jun; 120(24):1038-43. PubMed ID: 1272447
[No Abstract] [Full Text] [Related]
27. Management of Hodgkin's disease.
Desforges JF; Rutherford CJ
Compr Ther; 1979 Feb; 5(2):63-9. PubMed ID: 428209
[No Abstract] [Full Text] [Related]
28. [Treatment of advanced Hodgkin's disease: an analysis of 128 cases].
Zhou L; Wang Q; Feng F
Zhonghua Zhong Liu Za Zhi; 2000 Jul; 22(4):333-5. PubMed ID: 11778565
[TBL] [Abstract][Full Text] [Related]
29. Are ABVD and MOPP/ABV truly equivalent for treating Hodgkin's disease at advanced stages?
Andrieu JM; Colonna P
J Clin Oncol; 1998 Jun; 16(6):2283. PubMed ID: 9626234
[No Abstract] [Full Text] [Related]
30. [Drug therapy of malignant lymphoma].
Ogawa M; Inagaki J
Rinsho Hoshasen; 1985 Oct; 30(11):1317-32. PubMed ID: 2418229
[No Abstract] [Full Text] [Related]
31. Childhood Hodgkin disease treated with COPP/ABV hybrid chemotherapy: a progress report.
Sagar TG; Chandra A; Raman SG
Med Pediatr Oncol; 2003 Jan; 40(1):66-9. PubMed ID: 12426693
[No Abstract] [Full Text] [Related]
32. Dibromdulcitol containing chemotherapeutic regimen in the treatment of childhood Hodgkin's disease.
Schuler D; Kardos G; Révész T
Neoplasma; 1988; 35(5):599-603. PubMed ID: 3216934
[TBL] [Abstract][Full Text] [Related]
33. [MOPP chemotherapy of generalized Hodgkin's disease].
Zieliński T; Krajewska B; Solska E; Karnicka-Młodkowska H
Nowotwory; 1978 Dec; 28(4):453-9. PubMed ID: 733603
[No Abstract] [Full Text] [Related]
34. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
[TBL] [Abstract][Full Text] [Related]
35. [Treatment of recurrences of lymphogranulomatosis].
Kovryzhkina TA
Med Radiol (Mosk); 1984 Jan; 29(1):35-9. PubMed ID: 6546406
[No Abstract] [Full Text] [Related]
36. [Experiences with combined cyclic chemotherapy (COPP type) in advanced lymphogranulomatosis].
Búzás E; Rák K
Orv Hetil; 1975 Dec; 116(50):2931-5. PubMed ID: 1196632
[No Abstract] [Full Text] [Related]
37. [Hodgkin's disease in childhood: long term results].
Cramer P; Schaison G; Andrieu JM; Boiron M; Bernard J
Arch Fr Pediatr; 1982 Apr; 39(4):223-9. PubMed ID: 6896975
[TBL] [Abstract][Full Text] [Related]
38. Nitroblue tetrazolium test in patients with Hodgkin's disease in the course of chemotherapy.
Kemona H; Wysocka J; Prokopowicz J; Kiluk S
Neoplasma; 1987; 34(1):107-13. PubMed ID: 3561600
[TBL] [Abstract][Full Text] [Related]
39. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E
Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727
[TBL] [Abstract][Full Text] [Related]
40. [Ten-year outcomes of lymphogranulomatosis treatment according to the protocol MOPP-ABVD+radiotherapy].
Pivnik AV; Rastrigin NA; Moiseeva TN; Lutsenko IN; Dudarova RG; Shavlokhov VS; Efimov IV; Kozhurin SV; Shitareva IV; Gemdzhian EG; Tsyba NN; Kolosova LIu; Melikian AL; Skidan NI; Pan'shin GA; Sotnikov VM; Dotsenko PV; Nechistiuk AV
Ter Arkh; 2006; 78(8):57-62. PubMed ID: 17078219
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
